Wednesday, December 21, 2016 7:28:25 PM
"UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
September 26, 2016
ORDER GRANTING CONF
IDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Patriot Scientific Corporation
File No. 0-22182 - CF#34202
_____________________
Patriot Scientific Corporation subm
itted an application under Rule 24b-2
requesting confidential treatment for informati
on it excluded from the Exhibits to a Form
8-K filed August 16, 2016.
Based on representations by Patriot Scient
ific Corporation that this information
qualifies as confidential commercial or fi
nancial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Divi
sion of Corporation Finance has determined
not to publicly disclose it. Accordingl
y, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhib
it 10.1
through
August 16, 2020
For the Commission, by the Division of
Corporation Finance, pursuant to
delegated authority:
Brent J. Fields
Secretary"
Recent CPMV News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 05:17:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 06:44:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM